Page last updated: 2024-09-05

sb 203580 and stattic

sb 203580 has been researched along with stattic in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(stattic)
Trials
(stattic)
Recent Studies (post-2010) (stattic)
3,48941,1371420130

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)stattic (IC50)
Signal transducer and activator of transcription 3Homo sapiens (human)5.1
Hypoxia-inducible factor 1-alphaHomo sapiens (human)0.043
Thioredoxin glutathione reductase Schistosoma mansoni2.01

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartsch, S; Klettner, A; Lassen, J; Roider, J; Westhues, D1

Other Studies

1 other study(ies) available for sb 203580 and stattic

ArticleYear
Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.
    Molecular vision, 2013, Volume: 19

    Topics: Animals; Choroid; Chromones; Cinnamates; Cyclic S-Oxides; Imidazoles; Indazoles; Indoles; Maleimides; MAP Kinase Signaling System; Morpholines; NF-kappa B; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plicamycin; Pyridines; Retinal Pigment Epithelium; Signal Transduction; Sus scrofa; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2013